Loeb S, Berglund A, Stattin P.
“Population-Based Study of Utilization and Determinants of Active Surveillance and Watchful Waiting for Low- and Intermediate-Risk Prostate Cancer”
Journal of Urology 2013 May 29 epub. PMID: 23727309
Link: http://www.ncbi.nlm.nih.gov/pubmed/23727309
Using nationwide Sweden data, this study showed that from 2007 to 2011, active surveillance was selected by 59% of very low risk, 41% of low risk and 16% of intermediate risk patients across the country. These rates are the highest yet reported internationally. Dissociating diagnosis from treatment in men with a low risk of progression can decrease the rate of overtreatment.